Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

284 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Defining the best cut-off value for lymphopenia in diffuse large B cell lymphoma treated with immuno-chemotherapy.
Bari A, Tadmor T, Sacchi S, Marcheselli L, Cox C, Liardo EV, Pozzi S, Benyamini N, Avivi I, Ferrari A, Baldini L, Falorio S, Gobbi P, Federico M, Polliack A. Bari A, et al. Among authors: gobbi p. Br J Haematol. 2014 Oct;167(1):133-6. doi: 10.1111/bjh.12930. Epub 2014 May 3. Br J Haematol. 2014. PMID: 24797533 Free article. No abstract available.
Absolute monocyte count at diagnosis could improve the prognostic role of early FDG-PET in classical Hodgkin lymphoma patients.
Bari A, Marcheselli L, Marcheselli R, Pozzi S, Cox MC, Baldessari C, Ferri P, Gobbi P, Baldini L, Tadmor T, Musto P, Federico M, Sacchi S. Bari A, et al. Among authors: gobbi p. Br J Haematol. 2018 Feb;180(4):600-602. doi: 10.1111/bjh.14406. Epub 2016 Oct 26. Br J Haematol. 2018. PMID: 27785782 Free PMC article. No abstract available.
The length of treatment of aggressive non-Hodgkin's lymphomas established according to the international prognostic index score: long-term results of the GISL LA03 study.
Federico M, Luminari S, Gobbi PG, Sacchi S, Di Renzo N, Lombardo M, Merli F, Baldini L, Stelitano C, Partesotti G, Polimeno G, Montanini A, Mammi C, Brugiatelli M. Federico M, et al. Eur J Haematol. 2006 Mar;76(3):217-29. doi: 10.1111/j.1600-0609.2005.00609.x. Eur J Haematol. 2006. PMID: 16451396 Clinical Trial.
Absolute Monocyte Count and Lymphocyte-Monocyte Ratio Predict Outcome in Nodular Sclerosis Hodgkin Lymphoma: Evaluation Based on Data From 1450 Patients.
Tadmor T, Bari A, Marcheselli L, Sacchi S, Aviv A, Baldini L, Gobbi PG, Pozzi S, Ferri P, Cox MC, Cascavilla N, Iannitto E, Federico M, Polliack A. Tadmor T, et al. Among authors: gobbi pg. Mayo Clin Proc. 2015 Jun;90(6):756-64. doi: 10.1016/j.mayocp.2015.03.025. Mayo Clin Proc. 2015. PMID: 26046410 Free article.
Neutrophil-lymphocyte ratio at diagnosis is an independent prognostic factor in patients with nodular sclerosis Hodgkin lymphoma: results of a large multicenter study involving 990 patients.
Marcheselli R, Bari A, Tadmor T, Marcheselli L, Cox MC, Pozzi S, Ferrari A, Baldini L, Gobbi P, Aviv A, Pugliese G, Federico M, Polliack A, Sacchi S. Marcheselli R, et al. Among authors: gobbi p. Hematol Oncol. 2017 Dec;35(4):561-566. doi: 10.1002/hon.2359. Epub 2016 Oct 28. Hematol Oncol. 2017. PMID: 27791277 Free PMC article.
Improving the international prognostic index score using peripheral blood counts: Results of a large multicenter study involving 520 patients with diffuse large B cell lymphoma.
Marcheselli R, Bari A, Tadmor T, Marcheselli L, Cox MC, Papotti R, Ferrari A, Baldini L, Gobbi P, Levy I, Pugliese G, Federico M, Polliack A, Pozzi S, Sacchi S. Marcheselli R, et al. Among authors: gobbi p. Hematol Oncol. 2020 Oct;38(4):439-445. doi: 10.1002/hon.2757. Epub 2020 Jun 17. Hematol Oncol. 2020. PMID: 32495944 Free PMC article.
Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study.
Federico M, Guglielmi C, Luminari S, Mammi C, Marcheselli L, Gianelli U, Maiorana A, Merli F, Bellei M, Pozzi S, Stelitano C, Lazzaro A, Gobbi PG, Baldini L, Bergantini S, Fregoni V, Brugiatelli M. Federico M, et al. Haematologica. 2007 Nov;92(11):1482-8. doi: 10.3324/haematol.11502. Haematologica. 2007. PMID: 18024396 Free article.
Cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab versus epirubicin, cyclophosphamide, vinblastine, prednisone and rituximab for the initial treatment of elderly "fit" patients with diffuse large B-cell lymphoma: results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi.
Merli F, Luminari S, Rossi G, Mammi C, Marcheselli L, Tucci A, Ilariucci F, Chiappella A, Musso M, Di Rocco A, Stelitano C, Alvarez I, Baldini L, Mazza P, Salvi F, Arcari A, Fragasso A, Gobbi PG, Liberati AM, Federico M. Merli F, et al. Among authors: gobbi pg. Leuk Lymphoma. 2012 Apr;53(4):581-8. doi: 10.3109/10428194.2011.621565. Epub 2011 Nov 15. Leuk Lymphoma. 2012. PMID: 21895543 Clinical Trial.
284 results